Valion Bio VBIO
NASDAQ VBIO
$0.54 +0.02 (+3.85%)
At close: Nov 13, 2026 · 4:00 PM EST

Valion Bio (VBIO) Times Interest Earned (2021 - 2026)

Updated

Valion Bio's Times Interest Earned was -9.30 in Q2 2026.

Analysis

Valion Bio (VBIO) Times Interest Earned (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Valion Bio's Times Interest Earned was -10.57 through Jun 30, 2026; for FY2025, it came in at -54.10.

  • The Q2 2026 figure marks the highest quarterly Times Interest Earned since Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 28.50
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 9.20
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 5.68
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 12.87
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Valion Bio 73,008.00 -25.39 Mn - -9.30
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.30
Mar 31, 2026 -8.69
Jun 30, 2021 -4.73
Mar 31, 2021 -3.86
API Access

Valion Bio Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=VBIO&period=max&api_key=YOUR_API_KEY